Multi-omics reveals Dengzhan Shengmai formulation ameliorates cognitive impairments in D-galactose-induced aging mouse model by regulating CXCL12/CXCR4 and gut microbiota
Dengzhan Shengmai (DZSM), a traditional Chinese medicine formulation, has been administered extensively to elderly individuals with cognitive impairment (CI). However, the underlying mechanisms by which Dengzhan Shengmai improves cognitive impairment remains unknown. This study aimed to elucidate th...
Saved in:
Main Authors: | Jing-Yi Hou (Author), He Xu (Author), Guang-Zhao Cao (Author), Liang-Liang Tian (Author), Li-Han Wang (Author), Nai-Qiang Zhu (Author), Jing-Jing Zhang (Author), Hong-Jun Yang (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2023-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Altered synaptic currents, mitophagy, mitochondrial dynamics in Alzheimer's disease models and therapeutic potential of Dengzhan Shengmai capsules intervention
by: Binbin Zhao, et al.
Published: (2024) -
Integrating RNA-sequencing and network analysis to explore the mechanism of topical Pien Tze Huang treatment on diabetic wounds
by: Guang-Zhao Cao, et al.
Published: (2024) -
Active components of Dengzhan Shengmai ameliorate cognitive impairment by facilitating hippocampal long-term potentiation via the NMDA receptor-mediated Ca2+/CaMKII pathway
by: Congyu Ma, et al.
Published: (2024) -
The Role of the CXCL12/CXCR4/CXCR7 Chemokine Axis in Cancer
by: Yi Shi, et al.
Published: (2020) -
In vivo and in vitro protective effects of shengmai injection against doxorubicin-induced cardiotoxicity
by: Peng Zhou, et al.
Published: (2022)